Real World Solutions
Evidence built to inform decisions and deliver value
The growing demand for real world evidence
Decision makers today demand evidence that reflects real clinical practice and meets rising regulatory and payer expectations. ICON Real World Solutions delivers scientifically rigorous real world evidence (RWE) to support development, authorisation and commercial success.
We bring together global operations, advanced data technologies and deep epidemiological expertise in a single, integrated real world evidence ecosystem.
Evidence across the development lifecycle
Our evidence generation progresses in depth and impact from early proof of concept through phase 4 and post-approval commitments. From pragmatic trials and registries to large scale database analyses and external control arms, we design evidence strategies that evolve with your asset.
Global delivery at scale
-
750+
Real world studies spanning 20+ therapeutic areas -
259,000+
Patients -
36,100+
Sites worldwide -
950+
RWE project managers, epidemiologists, health economists, biostasticians, medical writers, and data scientists
An integrated real world evidence model
ICON uniquely combines scientific leadership, global execution and advanced data technologies into a single, cohesive RWE platform using a layered evidence strategy.
Primary data from registries, non-interventional studies, pragmatic trials and extension studies
Secondary data from claims, electronic health records, disease registries and social determinants of health
Complementary sources including patient reported outcomes, surveys, wearables and laboratory data
Advanced analytics powered by AI and machine learning
Solutions and services to support real world studies
- Patient Centred Outcomes Meeting the demands for high quality patient-centred data
- Mapi Research Trust Improving patients’ quality of life by facilitating access to clinical outcome assessments
- Language Services Delivering custom translation programs to meet the needs of your study
- Decentralised/Hybrid/Virtual Trials End-to-end services, operational model and technology to deliver customised solutions
- Clinical Trial Tokenisation Enhanced evidence generation for your drug development programme
- Post-marketing pharmacovigilance Safeguarding patients beyond approval
Patient Centred Outcomes
Meeting the demands for high quality patient-centred data
Mapi Research Trust
Improving patients’ quality of life by facilitating access to clinical outcome assessments
Language Services
Delivering custom translation programs to meet the needs of your study
Decentralised/Hybrid/Virtual Trials
End-to-end services, operational model and technology to deliver customised solutions
Clinical Trial Tokenisation
Enhanced evidence generation for your drug development programme
Post-marketing pharmacovigilance
Safeguarding patients beyond approval
Case studies
See our real world solutions in action through case studies spanning diverse study designs and therapeutic areas, supported by deep scientific expertise.